Titan Pharmaceuticals Inc
NASDAQ:TTNP

Watchlist Manager
Titan Pharmaceuticals Inc Logo
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Watchlist
Price: 4.61 USD Market Closed
Market Cap: 6.1m USD

Relative Value

TTNP doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of TTNP.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TTNP Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
5
Median 3Y
21.1
Median 5Y
6.6
Industry
2.6
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.2
Industry
21.6
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.4
Industry
16.5
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.3
Industry
22.5
vs History
33
vs Industry
47
Median 3Y
1.3
Median 5Y
1.9
Industry
2.3
vs History
vs Industry
14
Median 3Y
-2.4
Median 5Y
2.8
Industry
2.9
vs History
vs Industry
34
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
55
Median 3Y
-0.4
Median 5Y
-0.7
Industry
13
vs History
vs Industry
51
Median 3Y
-0.4
Median 5Y
-0.7
Industry
16.6
vs History
vs Industry
55
Median 3Y
-0.4
Median 5Y
-0.9
Industry
15.8
vs History
vs Industry
42
Median 3Y
-0.4
Median 5Y
-0.9
Industry
19.1
vs History
1
vs Industry
13
Median 3Y
9.9
Median 5Y
8.3
Industry
1.9

Multiples Across Competitors

TTNP Competitors Multiples
Titan Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
6.1m USD 0 -1.3 -0.7 -0.7
US
Eli Lilly and Co
NYSE:LLY
999.6B USD 16.8 54.3 36.4 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
501.2B USD 5.4 20 16.3 21.2
CH
Roche Holding AG
SIX:ROG
254.4B CHF 4.1 27 11.5 13.5
UK
AstraZeneca PLC
LSE:AZN
210.1B GBP 4.8 29.9 108.3 158.5
CH
Novartis AG
SIX:NOVN
206.7B CHF 4.6 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
250.5B USD 3.9 13.2 9.4 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13 9.1 10.6
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
142.4B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Average P/E: 23.7
Negative Multiple: -1.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
27
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Average EV/EBITDA: 438.7
Negative Multiple: -0.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Average EV/EBIT: 1 881.2
Negative Multiple: -0.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.5
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3